DYAI earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -6.11. Updated 2026-07-23.
Dyadic International (DYAI) Research Hub
Dyadic International (DYAI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.484 USD (-5.82%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.11, market cap 0.05B. This hub links to the full technical, earnings and options research available for DYAI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.484 USD (-5.82%) |
| 52-week range | 0.46 USD – 1.6 USD |
| Trend regime | Range |
| 14-day RSI | 11.9 (Oversold) |
| Trailing P/E | -6.11 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for DYAI
Covered Call on DYAI: how it works, illustrative setup around the real 0.484 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DYAI: how it works, illustrative setup around the real 0.484 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DYAI: how it works, illustrative setup around the real 0.484 USD price, max profit/loss, breakeven and when to use it. Educational.
DYAI technical analysis: range, last 0.484 USD, RSI 11.9, 52w range 0.46 USD–1.6 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is DYAI in?
Dyadic International (DYAI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is DYAI in an uptrend or downtrend?
As of 2026-09-11, DYAI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DYAI's trailing P/E ratio?
DYAI's trailing P/E is -6.11, with a market cap of 0.05B. See the earnings research page for full valuation detail.
When does DYAI next report earnings?
DYAI is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.03 USD.